In patients with AML, serum Ang-1 and Ang-2 levels were shown to be significantly lower and higher, compared with healthy controls and patients with myeloproliferative neoplasms (MPN), respectively [59]. Here, ANGPT2 is linked to acute myeloid leukemia.